Lysosomal Polygenic Burden Drives Cognitive Decline in Parkinson's Disease with Low Alzheimer Risk
Movement Disorders · 2024-03 · 39 (3) · 596-601
DOI: 10.1002/mds.29698 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 20.12.2023. Verfasst von Jon-Anders Tunold und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Parkinson Disease, Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Helse Sør-Øst RHF.
Themen: Demenz
Abstract (Originalsprache)
Background
Genetics influence cognitive progression in Parkinson's disease, possibly through mechanisms related to Lewy and Alzheimer's disease pathology. Lysosomal polygenic burden has recently been linked to more severe Lewy pathology post mortem.
Objectives
To assess the influence of lysosomal polygenic burden on cognitive progression in Parkinson's disease patients with low Alzheimer's disease risk.
Methods
Using Cox regression we assessed association between lysosomal polygenic scores and time to Montreal Cognitive Assessment score ≤ 21 in the Parkinson's Progression Markers Initiative cohort (n = 374), with replication in data from the Parkinson's Disease Biomarker Program (n = 777). Patients were stratified by Alzheimer's disease polygenic risk.
Results
The lysosomal polygenic score was associated with faster progression of cognitive decline in patients with low Alzheimer's disease risk in both datasets ( P = 0.0032 and P = 0.0054, respectively).
Conclusion
Our study supports complex interplay between genetics and neuropathology in Parkinson's disease‐related cognitive impairment, emphasizing the role of lysosomal polygenic burden. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Oslo University Hospital, Oslo, Norway.
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
- Mayo Clinic, Department of Neuroscience, Jacksonville, Florida, USA.
- Department of Anatomy and Neurosciences, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.
- Amsterdam Neuroscience, Program Neurodegeneration, Amsterdam, The Netherlands.
ORCID-Profile: Owen Ross, Lasse Pihlstrøm
Förderung
- Helse Sør-Øst RHF
Zitieren
APA
Tunold, J. A., Tan, M. M. X., Toft, M., Ross, O., van de Berg, W. D. J., & Pihlstrøm, L. (2024). Lysosomal Polygenic Burden Drives Cognitive Decline in Parkinson's Disease with Low Alzheimer Risk. Movement Disorders, 39(3), 596-601. https://doi.org/10.1002/mds.29698
Vancouver
Tunold JA, Tan MMX, Toft M, Ross O, van de Berg WDJ, Pihlstrøm L. Lysosomal Polygenic Burden Drives Cognitive Decline in Parkinson's Disease with Low Alzheimer Risk. Movement Disorders. 2024;39(3):596-601. doi:10.1002/mds.29698
BibTeX
@article{Tunold2024,
author = {Tunold, Jon-Anders and Tan, Manuela M X and Toft, Mathias and Ross, Owen and van de Berg, Wilma D J and Pihlstrøm, Lasse},
title = {Lysosomal Polygenic Burden Drives Cognitive Decline in Parkinson's Disease with Low Alzheimer Risk},
journal = {Movement Disorders},
year = {2024},
volume = {39},
number = {3},
pages = {596--601},
doi = {10.1002/mds.29698}
}
EUVIMED